SCHEMBL8360431

SCHEMBL8360431

COC(=O)[C@@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 7/20 0.50
▸ CASP6 P55212 6/20 0.50
▸ CASP8 Q14790 6/20 0.50
▸ ALDH1A1 P00352 5/20 0.46
▸ LPAR1 Q92633 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ THRB P10828 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360434 0.86 ALDH1A1 (0.54) CASP3CASP6CASP8ALDH1A1SMN1; SMN2
SCHEMBL5493805 0.86 CASP3 (0.53) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL6448297 0.80 ALDH1A1 (0.55) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL5497665 0.78 ALDH1A1 (0.57) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL22390739 0.78 ALDH1A1 (0.57) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL8177381 0.77 ALDH1A1 (0.49) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL75658 0.76 POLB (0.60) ALDH1A1SMN1; SMN2THRBMEN1CYP2C9
SCHEMBL5497672 0.75 LPAR1 (0.52) ALDH1A1LPAR1THRBKMT2AGAA
SCHEMBL5493808 0.72 ALDH1A1 (0.53) CASP3CASP6CASP8ALDH1A1LPAR1
SCHEMBL13382332 0.72 ALDH1A1 (0.51) ALDH1A1LPAR1SMN1; SMN2THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003008374-A1 INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES IDUN PHARMACEUTICALS, INC. (US) 2003-01-30 — — WO disclosed
Send feedback